Werewolf Therapeutics updates on clinical trials, financial results, and plans for proprietary T cell engager development amidst strong cash position. Werewolf Therapeutics, Inc. announced significant ...
Metsera, Inc., a clinical-stage biopharmaceutical company focused on treating obesity and metabolic diseases, announced its first quarter 2025 financial results, highlighting significant progress in ...
Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...
STAFFORD, Texas - Greenwich LifeSciences, Inc. (NASDAQ:GLSI), a clinical-stage biopharmaceutical company valued at $163 million, has announced the commencement of analysis on the open label HLA data ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Compensation for clinical trial participants is a sensitive subject. However, it should not be taboo, because there is a major need for reform. Recognition of this need has led to sustained attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback